Concepedia

David A. Van Echo

DA

Statistics

Publications

43

Citations

3.5K

H-Index

28

Active since

1979

Affiliations

University of Maryland, Baltimore(Current)

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

University of Maryland Medical Center

University of Maryland Medical System

University of Chicago

David A. Van Echo is an author at University of Maryland, Baltimore specializing in pharmacology, medicine, and chemotherapy.

Publications per year

1979–2013

43

Publications

43

Hypersensitivity reactions from taxol.

R B Weiss, Ross C. Donehower, Peter H. Wiernik et al. · Journal of Clinical Oncology · 1990 · 1.2K citations

Medicine, Oncology, Pharmacology +9

Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.

Merrill J. Egorin, David A. Van Echo, Stuart J. Tipping et al. · PubMed · 1984 · 306 citations

Pharmacy, Oncology, Pharmacology +17

Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study.

David Parkinson, Jeff Abrams, Peter H. Wiernik et al. · Journal of Clinical Oncology · 1990 · 199 citations

Life Sciences, Immunology, Oncology +17

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum.

Merrill J. Egorin, David A. Van Echo, Eve A. Olman et al. · PubMed · 1985 · 191 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors.

Barbara A. Conley, Merrill J. Egorin, Nancy Tait et al. · PubMed · 1998 · 155 citations

Medicine, Oncology, Pharmacology +9

1–5 of 43